한글목차

세계의 혈액 관리 시장은 2024년에 136억 2,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 6.90%로 성장하여 203억 3,000만 달러에 이를 것으로 예측됩니다.

세계 혈액 관리 시장은 헌혈자 모집 및 채취부터 처리, 검사, 보관, 수혈에 이르기까지 안전하고 충분한 혈액 공급을 보장하기 위한 종합적인 프로세스와 기술을 포괄하고 있으며, 첨단 환자 혈액 관리 전략도 포함합니다. 시장 확대를 뒷받침하는 주요 요인으로는 수혈이 필요한 만성질환 증가, 전 세계 수술 건수 증가, 혈액제제를 필요로 하는 질환에 걸리기 쉬운 고령 인구 증가 등을 들 수 있습니다.

주요 시장 성장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 혈액 관리 시장 전망-세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 구성요소별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(기기, 부속품, 시약 및 키트, 소프트웨어)
  • 성분별(전혈, 적혈구, 혈장)
  • 최종사용자별(혈액은행, 병원, 진단 클리닉, 병리 검사실)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 혈액 관리 시장 전망-세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 구성요소별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 혈액 관리 시장 전망-세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 구성요소별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 혈액 관리 시장 전망-세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 구성요소별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 혈액 관리 시장 전망-세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 구성요소별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카공화국

제10장 남미의 혈액 관리 시장 전망-세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 구성요소별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 세계의 혈액 관리 시장 : SWOT 분석 - 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 구성요소별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B Braun Melsungen AG
• bioMerieux Inc.
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• F. Hoffmann-La Roche Ltd.

제16장 전략적 제안

제17장 회사 소개 및 면책조항

영문목차

The Global Blood Management Market, valued at USD 13.62 Billion in 2024, is projected to experience a CAGR of 6.90% to reach USD 20.33 Billion by 2030. The global blood management market encompasses the comprehensive set of processes and technologies involved in ensuring a safe, adequate, and efficient blood supply from donor recruitment and collection to processing, testing, storage, and transfusion, including advanced patient blood management strategies. Key drivers supporting market expansion include the increasing incidence of chronic diseases requiring transfusions, a rising volume of surgical procedures worldwide, and the growing elderly population predisposed to conditions necessitating blood products.

Key Market Drivers

The rising prevalence of chronic diseases and blood disorders profoundly drives demand within the global blood management market. Conditions such as sickle cell disease, thalassemia, and various cancers necessitate frequent transfusions and specialized blood products for patient survival and improved quality of life. For example, according to Frontiers in Public Health, August 27, 2024, "Sickle cell disease: a comparative perspective on global and national initiatives," approximately 300,000 infants are born annually with Sickle Cell Disease globally, primarily in sub-Saharan Africa, India, and the Middle East, establishing a continuous requirement for blood components. This pervasive need creates an expanding base for the blood management sector.

Key Market Challenges

A critical challenge impeding the growth of the global blood management market stems from the consistent need to maintain a sufficient and safe blood supply. This challenge is exacerbated by evolving donor demographics and increasingly stringent regulatory requirements, directly impacting the ability of blood establishments to sustain robust donor recruitment and retention programs. The fluctuations in donor availability necessitate significant operational investments in outreach and educational initiatives, diverting resources that could otherwise be allocated to market expansion or technological advancements.

Key Market Trends

The shift towards personalized blood management strategies represents a significant evolution in patient care, moving beyond standardized transfusion protocols to tailored interventions based on individual patient needs. This approach focuses on optimizing a patient's own blood health, minimizing unnecessary transfusions, and thereby reducing associated risks such as infections and adverse reactions. For instance, according to an AABB review of current advances in 2024, treating iron deficiency anemia with intravenous iron significantly reduced postoperative red blood cell transfusions by 70%, improving patient outcomes. This trend influences the market by driving demand for advanced diagnostic tools to assess patient-specific factors like anemia and coagulation status, along with pharmacological alternatives to blood

Key Market Players

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B Braun Melsungen AG
• bioMerieux Inc.
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• F. Hoffmann-La Roche Ltd.

Report Scope:

In this report, the Global Blood Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Management Market, By Product:

• Instruments
• Accessories
• Reagents & Kits
• Software

Blood Management Market, By Component:

• Whole Blood
• Red Blood Cells
• Plasma

Blood Management Market, By End User:

• Blood Banks
• Hospitals
• Diagnostic Clinics
• Pathology Labs

Blood Management Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Blood Management Market.

Available Customizations:

Global Blood Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Accessories, Reagents & Kits, Software)
  • 5.2.2. By Component (Whole Blood, Red Blood Cells, Plasma)
  • 5.2.3. By End User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Blood Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Component
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Blood Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Blood Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End User

7. Europe Blood Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Component
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End User
  • 7.3.2. France Blood Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Blood Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Blood Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End User

8. Asia Pacific Blood Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Component
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Blood Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Blood Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Component
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Blood Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Blood Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End User

10. South America Blood Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Component
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Blood Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Blood Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Haemonetics Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fresenius SE & Co. KGaA
• 15.3. Terumo Corporation
• 15.4. Immucor, Inc.
• 15.5. B Braun Melsungen AG
• 15.6. bioMerieux Inc.
• 15.7. Kaneka Corporation
• 15.8. Bio-Rad Laboratories, Inc.
• 15.9. Grifols, S.A.
• 15.10. F. Hoffmann-La Roche Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer